Announced
Completed
Financials
Tags
Merger
Friendly
Cross Border
Single Bidder
Private
cancer medicines
Private Equity
Reverse Takeover
Pharmaceuticals
Acquisition
Majority
Israel
De-SPAC
Completed
Synopsis
Alpha Tau Medical, a cancer pharmaceutical company, went public via a SPAC merger with Healthcare Capital, a special purposes acquisition company, in a $1bn deal. "We thank our investors, both new joiners as well as those who have supported us for years, who continue to demonstrate their faith in the company and its leadership. The completion of this transaction will allow the company to realize its vision and implement the clinical development plans and construction of our manufacturing plants around the world, in order to bring hope to millions of patients around the world," Uzi Sofer, Alpha Tau CEO and Chairman.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.